Advertisement

Topics

Sienna CEO: IPO Investors Drawn By Experienced Dermatology Team

18:57 EDT 2 Aug 2017 | SCRIP

Sienna Biopharmaceuticals went from Series A to IPO in 15 months, selling investors on its executive team experienced in the...

      

Related Stories

 

Original Article: Sienna CEO: IPO Investors Drawn By Experienced Dermatology Team

NEXT ARTICLE

More From BioPortfolio on "Sienna CEO: IPO Investors Drawn By Experienced Dermatology Team"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...